Product Details
Product Name:
Aristeromycin |
CAS No.:
19186-33-5 |
Purity:
99.34% |
Supply Ability:
10g |
Release date:
2024/11/05 |
Product Introduction
Bioactivity
名稱 | Aristeromycin |
描述 | Aristeromycin (U 99468) is a broad-spectrum antiviral antibiotic that targets RNA viruses and is an inhibitor of S-adenosylhomocysteine hydrolase (AHCY). |
體外活性 | DZNeP and Aristeromycin exhibit potent inhibitory activity against AHCY. Treatment of prostate cancer cells with DZNeP leads to accumulation of SAH and reduction in levels of homocysteine and histone H3K27 methylation. Confirmation of SAH accumulation and growth inhibition was achieved upon siRNA-mediated knockdown of AHCY[1]. |
存儲條件 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 30 mg/mL (113.09 mM), Sonication is recommended.
|
關(guān)鍵字 | Aristeromycin |
相關(guān)產(chǎn)品 | BTA-188 | (+)-Usnic acid | 2,2'-Anhydrouridine | Vidarabine phosphate | Oxytetracycline Hydrochloride | Rociclovir PM | Valganciclovir hydrochloride | Moroxydine hydrochloride | Arbidol | 3-Methoxycatechol |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:93206-09-8
$0.00 / 100mg
-
CAS:721431-18-1
$0.00 / 100mg
-
CAS:125-02-0
$35.00 / 100mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$2500.00/100mg |
VIP1Y
|
TargetMol Chemicals Inc.
|
2024-10-23 |